KDM3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.573600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.803200E-01
Normal-vs-Stage2
2.637200E-01
Normal-vs-Stage3
5.288300E-02
Normal-vs-Stage4
8.969600E-01
Stage1-vs-Stage2
4.005000E-01
Stage1-vs-Stage3
1.135660E-02
Stage1-vs-Stage4
4.525400E-01
Stage2-vs-Stage3
8.413800E-02
Stage2-vs-Stage4
1.264630E-01
Stage3-vs-Stage4
8.020500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.191600E-01
Normal-vs-AfricanAmerican
2.788000E-01
Normal-vs-Asian
6.281600E-01
Caucasian-vs-AfricanAmerican
8.718200E-01
Caucasian-vs-Asian
7.379400E-01
AfricanAmerican-vs-Asian
7.504200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.742000E-01
Normal-vs-Female
2.519200E-01
Male-vs-Female
8.191600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.411800E-01
Normal-vs-Age(41-60Yrs)
5.772000E-01
Normal-vs-Age(61-80Yrs)
1.709970E-01
Normal-vs-Age(81-100Yrs)
1.028160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.141800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.323600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.326000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.336900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.087500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.257800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.481400E-01
Normal-vs-Daily Drinker
1.487240E-01
Normal-vs-Weekly Drinker
2.713800E-01
Normal-vs-Occasional Drinker
6.094000E-01
Normal-vs-Social Drinker
3.266000E-01
Non Drinker-vs-Daily Drinker
4.054400E-01
Non Drinker-vs-Weekly Drinker
5.416200E-01
Non Drinker-vs-Occasional Drinker
3.459600E-01
Non Drinker-vs-Social Drinker
6.025800E-01
Daily Drinker-vs-Weekly Drinker
9.585600E-01
Daily Drinker-vs-Occasional Drinker
8.470300E-02
Daily Drinker-vs-Social Drinker
1.629580E-01
Weekly Drinker-vs-Occasional Drinker
1.856850E-01
Weekly Drinker-vs-Social Drinker
3.033800E-01
Occasional Drinker-vs-Social Drinker
6.512000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.623800E-02
Normal-vs-Grade 2
3.744900E-03
Normal-vs-Grade 3
2.240500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.954600E-01
Grade 1-vs-Grade 3
7.003700E-02
Grade 1-vs-Grade 4
3.623800E-02
Grade 2-vs-Grade 3
1.961380E-01
Grade 2-vs-Grade 4
3.744900E-03
Grade 3-vs-Grade 4
2.240500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.774640E-01
Normal-vs-NonDiabetic
2.934000E-01
Diabetic-vs-NonDiabetic
1.967160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.225600E-01
Normal-vs-NoPancreatitis
2.569800E-01
Pancreatitis-vs-NoPancreatitis
6.761800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.832400E-01
Normal-vs-N1
2.614600E-01
N0-vs-N1
7.887200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.834800E-01
Normal-vs-TP53-NonMutant
5.334200E-01
TP53-Mutant-vs-TP53-NonMutant
3.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
